Doses to organs at risk in conformational radiotherapy and stereotaxic irradiation: The heart

• Published in: Cancer radiothérapie 2017-10, Vol.21 (6-7), p.626
• Main Authors: Vandendorpe, B, Servagi Vernat, S, Ramiandrisoa, F, Bazire, L, Kirova, Y M
• Format: Article
• Language: fre ; spa
• Subjects: Heart - radiation effects; Hodgkin Disease; Humans; Organs at Risk - radiation effects; Practice Guidelines as Topic; Radiosurgery - adverse effects; Radiotherapy Dosage; Radiotherapy, Conformal - adverse effects; Thoracic Neoplasms - radiotherapy
• ISSN: 1769-6658
• DOI: 10.1016/j.canrad.2017.07.044

Radiation therapy of breast cancer, Hodgkin lymphoma, lung cancer and others thoracic irradiations induce an ionizing radiation dose to the heart. Irradiation of the heart, associated with patient cardiovascular risk and cancer treatment-induced cardiotoxicity, increase cardiovascular mortality. The long survival after breast or Hodgkin lymphoma irradiation requires watching carefully late treatment toxicity. The over-risk of cardiac events is related to the dose received by the heart and the irradiated cardiac volume. The limitation of cardiac irradiation should be a priority in the planning of thoracic irradiations. Practices have to be modified, using modern techniques to approach of the primary objective of radiotherapy which is to optimize the dose to the target volume, sparing healthy tissues, in this case the heart. We have reviewed the literature on cardiac toxicity induced by conformational tridimensional radiation therapy, intensity-modulated radiation therapy or stereotactic body radiation therapy, in order to evaluate the possibilities to limit cardiotoxicity. Finally, we summarise the recommendations on dose constraints to the heart and coronary arteries.